Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

In our continued commitment to develop an artificial pancreas, Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) to conduct a pivotal in-home clinical trial protocol for the ASPIRE study of the MiniMed Paradigm System featuring Low Glucose Suspend (LGS) automation.

From Medtronic 29 Oct 2011

Merck third quarter global sales increase 8% to $12.0 billion

Merck, known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2011.

29 Oct 2011

Specific metabolic disturbances precede children's progression to Type 1 diabetes

New potential avenues for early disease detection and prevention: A study led by Matej Orešič from VTT Technical Research Centre of Finland suggests that autoimmune diabetes is preceded by diminished gut microbial diversity of the Clostridium leptum subgroup, elevated plasma leptin and enhanced glucose-stimulated insulin secretion.

29 Oct 2011

Sulodexide drug fails to benefit diabetes patients with kidney disease

What was hoped to be a promising new drug to protect the kidneys has failed to benefit diabetes patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

28 Oct 2011

Diabetic patients with mild kidney disease may benefit from vitamin B6 derivative

A vitamin B6 derivative may help slow or prevent the progression of mild kidney disease in patients with diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

28 Oct 2011

Penn Nursing experts available to discuss stories on American Diabetes Month

Diabetes specialists at the University of Pennsylvania School of Nursing are available to talk with media for stories on American Diabetes Month.

27 Oct 2011

International diabetes researchers to engineer artificial pancreas system

The National Institutes for Health (NIH) have awarded $4.5 million to a group of international diabetes researchers to engineer an artificial pancreas system that will monitor and adapt to the body's complex real-time changes in behavior and physiology.

27 Oct 2011

Insulin resistance paradox

Obesity and insulin resistance are almost inevitably associated with increases in lipid accumulation in the liver, a serious disease that can deteriorate to hepatitis and liver failure. A real paradox in understanding insulin resistance is figuring out why insulin-resistant livers make more fat. Insulin resistance occurs when the body does a poor job of lowering blood sugars.

27 Oct 2011

NHMRC awards $2 million to investigate new therapies for reversing autoimmune disease

Research being undertaken at the University of Adelaide and Women's and Children's Hospital is providing vital clues into the causes of autoimmune diseases which affect millions of people around the world.

24 Oct 2011

Holtorf Medical Group opens new affiliate center in King of Prussia, Pennsylvania

Holtorf Medical Group, California's leading integrative, evidence-based medical facility, is pleased to announce the opening of its newest affiliate center, Garabedian Medical Clinic in King of Prussia, Pennsylvania.

24 Oct 2011

U-M researchers to study new approach in halting downward spiral of diabetes

University of Michigan Health System researchers will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.

24 Oct 2011

Women hospital staff working night shifts may face increased risk of heart disease

Women hospital staff working night shifts may be compromising their own health as they try to improve the health of patients, Dr. Joan Tranmer told the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

24 Oct 2011

VTT research exploits metabolics

VTT is seeking to create new development paths towards a healthier life. New opportunities created by metabolics in the fields of diagnostics, medical development, industrial biotechnology and environmental technology have been a part of VTT research for almost 10 years.

22 Oct 2011

Six young investigators receive IOF's Young Investigator Award for bone research

Six young investigators from the Middle East have been awarded prestigious grants in recognition of their top ranked research abstracts presented at the IOF Regionals - 1st Middle-East & Africa Osteoporosis Meeting.

22 Oct 2011

Higher diabetes rates in African American women after GDM

African American women who develop gestational diabetes mellitus during pregnancy face a 52 percent increased risk of developing diabetes in the future compared to white women who develop GDM during pregnancy, according to a Kaiser Permanente study published online in the journal Diabetologia.

21 Oct 2011

Byetta combination with insulin glargine gets FDA nod in type 2 diabetes

The US Food and Drugs Administration (FDA) has approved Byetta (exenatide) injection as add-on treatment for use with insulin glargine, together with exercise and diet for diabetes type 2 patients who are not responding well enough to glargine alone. Byetta's add-on therapy is for those on glargine with metformin and/or a TZD (thiazolidinedione) or without.

20 Oct 2011

Common link between Type 2 diabetes and autism

A review of the genetic and biochemical abnormalities associated with autism reveals a possible link between the widely diagnosed neurological disorder and Type 2 diabetes, another medical disorder on the rise in recent decades.

20 Oct 2011

Young adults born prematurely show multiple biological signs of risks to future health

Young adults who were born prematurely show multiple biological signs of risks to future health, research from Imperial College London has found. The scientists, reporting their findings tomorrow in the journal Pediatric Research, say that the research indicates that urgent work is now needed to monitor preterm babies into adulthood to improve the detection of early signs of disease.

19 Oct 2011

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiaries, Takeda Global Research & Development Center, Inc., and Takeda Global Research & Development Centre (Europe), Ltd., announced today the initiation of the Company's Phase 3 clinical trial program for TAK-875, an investigational therapy for type 2 diabetes.

18 Oct 2011

Nephron Dx to develop more accurate diagnostic kit for early detection of diabetic CKD

A new spin-off company from the National University of Singapore (NUS), called Nephron Dx, has recently been set up to develop a more accurate diagnostic kit for the earlier detection of diabetic chronic kidney disease. Nephron Dx aims to enter the multi-billion dollar kidney disease diagnostic market by 2013.

18 Oct 2011

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

Merck third quarter global sales increase 8% to $12.0 billion

Specific metabolic disturbances precede children's progression to Type 1 diabetes

Sulodexide drug fails to benefit diabetes patients with kidney disease

Diabetic patients with mild kidney disease may benefit from vitamin B6 derivative

Penn Nursing experts available to discuss stories on American Diabetes Month

International diabetes researchers to engineer artificial pancreas system

Insulin resistance paradox

NHMRC awards $2 million to investigate new therapies for reversing autoimmune disease

Holtorf Medical Group opens new affiliate center in King of Prussia, Pennsylvania

U-M researchers to study new approach in halting downward spiral of diabetes

Women hospital staff working night shifts may face increased risk of heart disease

VTT research exploits metabolics

Six young investigators receive IOF's Young Investigator Award for bone research

Higher diabetes rates in African American women after GDM

Byetta combination with insulin glargine gets FDA nod in type 2 diabetes

Common link between Type 2 diabetes and autism

Young adults born prematurely show multiple biological signs of risks to future health

Takeda commences TAK-875 Phase 3 clinical trial program for type 2 diabetes

Nephron Dx to develop more accurate diagnostic kit for early detection of diabetic CKD

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in